Researchers have discovered on-off switch behind several major diseases?
October 7, 2008 by admin · Leave a Comment
In the advance online edition of Nature Medicine, scientists from Sainte-Justine Hospital Research Center, the Université de Montréal and the Institut national de la santé et de la recherche médicale (INSERM) in France report how the GPR91 receptor contributes to activate unchecked vascular growth that causes vision loss in common blinding diseases. These findings could also have wide-ranging and positive implications for brain tissue regeneration.
Ovarian cancer drug trial reveals promising new treatment
September 15, 2008 by admin · Leave a Comment
UCI-led study shows effectiveness of first treatment to target and stop ovarian cancer cell growth
Women with recurrent ovarian cancer can be helped by an experimental therapy using a drug already touted for its ability to fight other cancers, a finding that provides hope for improved treatment of this deadly disease.
